JPH0247700B2 - - Google Patents
Info
- Publication number
- JPH0247700B2 JPH0247700B2 JP56063160A JP6316081A JPH0247700B2 JP H0247700 B2 JPH0247700 B2 JP H0247700B2 JP 56063160 A JP56063160 A JP 56063160A JP 6316081 A JP6316081 A JP 6316081A JP H0247700 B2 JPH0247700 B2 JP H0247700B2
- Authority
- JP
- Japan
- Prior art keywords
- liquid
- sample
- measurement
- blood
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000007788 liquid Substances 0.000 claims description 120
- 238000005259 measurement Methods 0.000 claims description 54
- 210000004369 blood Anatomy 0.000 claims description 45
- 239000008280 blood Substances 0.000 claims description 44
- 239000000243 solution Substances 0.000 claims description 19
- 239000007853 buffer solution Substances 0.000 claims description 14
- 239000012488 sample solution Substances 0.000 claims description 10
- 239000012086 standard solution Substances 0.000 claims description 6
- 239000012482 calibration solution Substances 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 4
- 108010093096 Immobilized Enzymes Proteins 0.000 claims description 3
- 239000000523 sample Substances 0.000 description 50
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 20
- 239000008103 glucose Substances 0.000 description 20
- 239000012895 dilution Substances 0.000 description 19
- 238000010790 dilution Methods 0.000 description 19
- 230000008859 change Effects 0.000 description 14
- 239000003146 anticoagulant agent Substances 0.000 description 13
- 229940127219 anticoagulant drug Drugs 0.000 description 13
- 101100441413 Caenorhabditis elegans cup-15 gene Proteins 0.000 description 12
- 238000005070 sampling Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 8
- 230000007246 mechanism Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000007410 oral glucose tolerance test Methods 0.000 description 4
- 238000010241 blood sampling Methods 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000012503 blood component Substances 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 102100021851 Calbindin Human genes 0.000 description 1
- 101710196208 Fibrinolytic enzyme Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101000898082 Homo sapiens Calbindin Proteins 0.000 description 1
- 101001021643 Pseudozyma antarctica Lipase B Proteins 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- -1 that is Substances 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
- A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/15003—Source of blood for venous or arterial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150221—Valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150229—Pumps for assisting the blood sampling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/155—Devices specially adapted for continuous or multiple sampling, e.g. at predetermined intervals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3672—Means preventing coagulation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00Â -Â G01N33/00; Handling materials therefor
- G01N35/10—Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ãè¡æ¶²äžã®ç¹å®æåã®æ¿åºŠãé£ç¶ããŠ
èªåçã«ç£èŠããè£
眮ã«é¢ãããDETAILED DESCRIPTION OF THE INVENTION The present invention relates to an apparatus for continuously and automatically monitoring the concentration of specific components in blood.
ãã詳ããã¯ãè¡ç®¡å
ç眮ã«ããŒãã«ã«ãã€ãŠ
æ£è
ããé£ç¶çã«è¡æ¶²ããµã³ããªã³ã°ããé·æé
é£ç¶ããŠç¹å®æåã®æ¿åºŠãèªåçã«æž¬å®ããã«ã
ããã枬å®æµè·¯ã圢æããããŠãŒããã³ãã®æµé
å€åã®åœ±é¿ããã³æ€åºåšã®ããªããã®åœ±é¿ãåã
ãªã枬å®è£
眮ãæäŸãããã®ã«é¢ããã More specifically, when blood is continuously sampled from a patient using an intravascular indwelling catheter and the concentration of a specific component is automatically measured over a long period of time, the flow rate fluctuation of the tube pump that forms the measurement flow path is The present invention relates to providing a measurement device that is immune to effects and detector drift.
å°ã以äžã«ãããŠã¯ãç¹ã«è¡æ¶²äžã®ã°ã«ã³ãŒã¹
å³ã¡è¡ç³ã«é¢ããŠèª¬æãé²ããããè¡ç³ã«éå®ã
ãããã®ã§ãªãããšã¯ãããŸã§ããªãã In the following, explanation will be given particularly regarding glucose in blood, that is, blood sugar, but it goes without saying that the explanation is not limited to blood sugar.
è¿æ¥ãåçš®ã®è² è·è©Šéšã«ãããè¡ç³å€å€åãã¿
ãŒã³ã®æž¬å®ããéçç³å°¿ç
æ£è
ã®ããããµã€ãã¢
ãã¿ãŒãç³å°¿ç
æ£è
ã®è¡äžã»è¡åŸã®è¡ç³ã¢ãã¿ãŒ
ãªã©ã«ã埮éã®è¡æ¶²ãé·æéé£ç¶ããŠæ¡åããŠè¡
ç³å€ãé£ç¶æž¬å®ããè£
眮ã®éçºãé²ããããŠã
ãã In recent years, blood glucose levels have been measured by continuously collecting small amounts of blood over long periods of time, for measuring blood glucose fluctuation patterns in various stress tests, for bedside monitoring of patients with severe diabetes, and for monitoring blood glucose levels during and after surgery for diabetic patients. Development of a device to continuously measure .
ãã®çš®è£
眮ã§ã¯ãæåè¡è¬æ³šå
¥å£ãæããäºé
管ã«ããŒãã«ãè¡ç®¡å
ã«ç眮ããæåè¡è¬ã§åžé
ãããªããçäœããæ¡è¡ãããè¡æ¶²ã¯ãé©åœãªã
ã³ãæ段ã«ããã»ã³ãµãŒãžéãããããããŠã»ã³
ãµãŒãèŒæ£ããå Žåã«ã¯ãäºé管ã«ããŒãã«ãã«
ããŠãŒã¬ããåãå€ããæ¢ç¥æ¿åºŠã®æ¶²ãçšããŠèŒ
æ£ããåŸãåã³ã«ããŠãŒã¬ã«æ¥ç¶ããŠæž¬å®ãç¶ã
ããããããã®æ¹åŒã¯æäœãç
©éã«ãªãã°ããã§
ãªããã»ã³ãµãŒèŒæ£æã«è¡æ¶²ãã«ããŠãŒã¬éšã§å
åºãããããšããæ¬ ç¹ãæããŠããã In this type of device, a double-tube catheter having an anticoagulant injection port is placed in a blood vessel, and blood collected from a living body while being diluted with an anticoagulant is sent to a sensor by an appropriate pump means. When calibrating the sensor, the double-tube catheter is removed from the cannula, calibrated using a solution of known concentration, and then connected to the cannula again to continue measurement. However, this method not only requires complicated operation, but also has the disadvantage that blood tends to coagulate in the cannula during sensor calibration.
ãããæ¬ ç¹ãåé¿ããããã«ãç¹éæ52â
135795ã§ã¯ãã»ã³ãµãŒã«è³ãæµè·¯ïŒããŠãŒããã³
ããçšããŠããïŒã«æµè·¯åæè£
眮ãèšããŠããã
ãã ãã®çºæè£
眮ã«ãããŠã¯ãããŠãŒããã³ã以
å€ã®ãã³ããçšããããšãããŠããããããŠãŒã
ãã³ã以å€äŸãã°ã·ãªã³ãžãã³ãã®å Žåã¯ãèå
ã倧ãã埮éãªåæµãã®äœçžãæ£ç¢ºã«æããããš
ã¯å°é£ã§ããŸããããããªãŠãŒã ã倧ããããšã
ãã埮éã®æ¶²äœãé£ç¶ããŠå®å®ããæµéã§é液ã
ãã«ã¯é©ããŠããªããããã§ããã®æ§ãªåŸ®éã®æ¶²
äœãæ±ãå Žåã«ã¯ããŠãŒããã³ããçšããã®ãæ®
éã§ãããããã¯ããŠãããäžèšæµè·¯åæè£
眮ã«
ã¯ãé£ç¶çã«æµããè©ŠææºãšèŒæ£æã«çšããåºæº
液äœæºãé£ç¶ãããŠãããéåžžã¯è©Šæãã»ã³ãµãŒ
éšãžæµããŠé£ç¶æž¬å®ãè¡ãªããäžæ¹ã»ã³ãµãŒã®èŒ
æ£ãè¡ãªãå Žåã¯ãåºæºæ¶²äœé¿ããã®æµè·¯ããªãŒ
ãã³ãšãªããã»ã³ãµãŒã«ã¯åºæºæ¶²äœãæµãããè©Š
æã¯æµãããããããŠã»ã³ãµãŒéšãéããã«ãã¬
ã€ã³éšãžãšæµãããããããããšã«ãããã»ã³ãµ
ãŒã®èŒæ£æã«ãããŠããã«ããŒãã«ãå€ãå¿
èŠã
ãªããäžã€è©Šæã¯æµããç¶æ
ã®ãŸãŸãªã®ã§ãååº
ãæããšããæ¬ ç¹ãåé¿ãããŠããã In order to avoid such drawbacks, Japanese Patent Laid-Open No. 52-
In 135795, a flow path switching device is installed in the flow path (using a tube pump) leading to the sensor.
However, it is said that pumps other than tube pumps can be used in the device of this invention, but in the case of a syringe pump other than a tube pump, for example, it is difficult to precisely align the phases of each minute flow due to large pulsations. Since the dead volume is large, it is not suitable for continuously delivering a small amount of liquid at a stable flow rate. Therefore, when handling such a small amount of liquid, a tube pump is usually used. Aside from that, the flow path switching device has a continuously flowing sample source and a reference liquid source used during calibration connected in series, and normally the sample is flowed to the sensor section for continuous measurement. On the other hand, when calibrating the sensor, the flow path from the reference liquid is opened, the reference liquid is allowed to flow through the sensor, and the flow of the sample is diverted and flows to the drain section without passing through the sensor section. In this way, even during sensor calibration, there is no need to remove the catheter, and the sample remains in a flowing state, thereby avoiding the disadvantage of easy coagulation.
ãŸããåºæºæ¶²äœã¯è©Šæã®åžéçãäžå®ã®æã«æ£
ããæ¿åºŠå€ã瀺ãããã«ã»ã³ãµãŒãèŒæ£ãããã®
ã§ããããå®éã«ã¯æµè·¯ïŒããŠãŒããã³ãïŒã®åŸ®
åŠãªå€åœ¢ç¶ã«ãããåžéçãèšå®ããå€ããå€å°
ãããŠãã®ãŸãŸã§ã¯æž¬å®ã«èª€å·®ãçããåŸåã«ã
ãã®ã§ããã®å
è¡æè¡ã§ã¯ä»¥äžã®åŠãæ¹æ³ãæ¡ã€
ãŠãããå³ã¡ãã«ããŠãŒã¬ããåžå
¥ãããè©Šæã®
ç·©è¡æ¶²çã«ããå®éã®åžéçãæ€ç¥ããããã«ã
è©Šæãšåäžãããã¯åçãšèŠåãã液ãæ¡åãã
äžå®ã®åžéçã«ãŠåžéããŠèŒæ£çšè©Šæãäœæãã
èŒæ£æã®æµè·¯ïŒããŠãŒããã³ãïŒããã»ã³ãµãŒãž
çŽæ¥æµããŠæž¬å®å€ãèªã¿åããã«ããŠãŒã¬ããè©Š
æãæµãããšãã®æž¬å®å€ãšæ¯èŒããããšã«ããå®
éã®åžéçãç¥ãã In addition, the reference liquid is used to calibrate the sensor so that it shows the correct concentration value when the dilution rate of the sample is constant, but in reality, due to the subtle deformation of the flow path (tube pump), the dilution rate is If the deviation is more or less than the value, it tends to cause errors in measurement, so this prior art adopts the following method. That is, in order to detect the actual dilution rate of the sample inhaled from the cannula with buffer solution, etc.
Collect a liquid that can be considered to be the same or equivalent to the sample,
Create a calibration sample by diluting it at a certain dilution rate,
The actual dilution rate can be determined by reading the measured value by flowing the sample directly from the flow path (tube pump) during calibration to the sensor and comparing it with the measured value when the sample was flowed from the cannula.
ãããããã®å
è¡æè¡ïŒç¹éæ52â135795ïŒ
ãã以äžã«è¿°ã¹ã解決ãã¹ãæ¬ ç¹ãå«ãã§ããã
ãããã¯è©Šææºãšåºæºæ¶²äœæºãå¥ã
ã®æµè·¯ããæ
ã€ãŠããããšã«åž°å ããã However, this prior art (Japanese Patent Application Laid-Open No. 52-135795)
However, it also has the following drawbacks that need to be resolved.
This is due to the fact that the sample source and the reference liquid source are comprised of separate channels.
å³ã¡ãå®éã«äžæ¬ã®ããŠãŒããã³ããé·æéé£
ç¶ããŠçšããå Žåã®æµéçæµãã®ç¶æ
ã®å€åã®åºŠ
åã¯ç¡èŠã§ããªã倧ãããæããŠãããäŸãã°10
æéé£ç¶ããŠäœ¿çšããå Žåã®æµéã®å€åã¯10ïŒ
ã
è¶ãããšãçãããã¯ãªãããã®æµãã®ç¶æ
ã®å€
åã®èŠå ãšããŠã¯ãããŠãŒãèªèº«ã®çµæå€åïŒã
ãŠãŒããã³ãã®ããŒã©ãŒå å§ã«ããïŒãšãããŠãŒ
ãå
å£ã«è¡çãèçœãã®ä»æ¶²äžã®äžçŽç©çãä»ç
ããŠæ±æãããããšã«äŸããã®ãšèãããããã
ã®å
åè
ã§ã¯ããŠãŒãã®èåã®éããæ質ã®é
ããæŽã«ã¯ããŠãŒããã³ãã®æ§é ã®åŸ®åŠãªå·®ç°ç
ã«ãããåããŠãŒãã®çµæå€åã¯åã
ç°ãªã€ãŠã
ãã®ã§ãå¥ã
ã®æµè·¯ç³»ãçšããå Žåã«ã¯åæ¹ã®å€
åã®åºŠåããæããããšã¯äžå¯èœãšèšã€ãŠãã
ãããŸãåŸè
ã®èŠå ã«ã€ããŠããå¥ã
ã®æµè·¯ç³»ã
çšããå Žåã«ã¯åæµè·¯ç³»ãå³ã¡è©Šææºãšåºæºæ¶²äœ
æºãšã§ã¯æµãã液äœã®è³ªãç°ãã®ã§äžå±€å·®ãçã
æãã In other words, when one tube pump is actually used continuously for a long time, the degree of change in flow conditions such as flow rate is large enough that it cannot be ignored.
It is not uncommon for the flow rate to change by more than 10% when used continuously for hours. The causes of this change in flow state are changes in the tube itself over time (due to tube pump roller pressure), and contamination due to adhesion of blood cells, proteins, and other impurities in the liquid to the inner wall of the tube. it is conceivable that. In the former case, the changes over time of each tube are different due to differences in tube wall thickness, material, and even subtle differences in the structure of the tube pump, so if separate flow path systems are used, It can be said that it is impossible to equalize the degree of change on both sides. Regarding the latter factor, when separate flow path systems are used, the quality of flowing liquid is different between each flow path system, that is, the sample source and the reference liquid source, so differences are more likely to occur.
åŸã€ãŠãé£ç¶æž¬å®äžã«ãããè©Šææºã®æµè·¯ãåº
æºæ¶²äœæºã®æµè·¯ã§ã®æµãã®ç¶æ
ã®å€åã®ä»æ¹ãç°
ãªãããšã«ãããè©Šæãšç·©è¡æ¶²ãšã®åžéççã枬
å®æã«åŸã
ã«å€åããã®ã§ã枬å®ã®éå§æã«å®é
ã®åžéçã枬å®ããŠè¡ãªã€ãèŒæ£ãããç¶æ
ã¯
åŸã
ã«ä¹±ããŠããããšããããè©Šææºã®æµè·¯ãšåº
æºæ¶²äœæºã®æµè·¯ã®çµæçãªæµãã®ç¶æ
ã®å€åã¯å
š
ãç¬ç«ããŠãããäºãã«è£åããããšã¯ã§ããª
ãããŸããåºæºæ¶²äœã«ãŠéæèŒæ£ãå¯èœãªã®ã¯ã»
ã³ãµãŒã®æ床ã ãã§ãããè©Šææºãšåºæºæ¶²äœæºãš
ã®æµè·¯ã®å€ååã®å·®ç°ãäŸãã°è©Šæ液ãšç·©è¡æ¶²ãš
ã®æ··åæ¯å³ã¡åžéçãå€åãããšããŠããããã¯
è£åãããããã®å Žåã®æž¬å®å€ã¯èª€ããå«ãã ã
ã®ãšãªãã Therefore, due to the difference in the way the flow conditions change between the sample source flow path and the reference liquid source flow path during continuous measurements, the dilution ratio of the sample and buffer solution will gradually change during measurement. , the calibrated conditions established by measuring the actual dilution rate at the beginning of the measurement gradually become disturbed. However, changes in the flow conditions over time in the sample source flow path and the reference liquid source flow path are completely independent and cannot compensate for each other. In addition, only the sensitivity of the sensor can be calibrated at any time using the reference liquid, and the difference due to fluctuations in the flow paths between the sample source and the reference liquid source, for example, the mixing ratio of the sample liquid and the buffer solution, that is, the dilution rate, has changed. However, it is not compensated for and the measured value in that case will contain an error.
ãŸããåèšè©Šæãšåäžãããã¯åçãšèŠåãã
èŒæ£çšè©Šæãçšããåžéçè£åæ段ã¯ãè©Šæäžã®
ã°ã«ã³ãŒã¹æ¿åºŠãèŒæ£ããŠããæéå
ã«å€åããª
ããšèŠåããå Žåã«ã¯æå¹ã§ããããå®éã«ã¯æž¬
å®äžã«ã°ã«ã³ãŒã¹æ¿åºŠãçµæžçãªå€åã瀺ããã®
ãæ®éã§ããããŸãã©ã®ããã«å€åããããç¥ã
ãªããã®ã§ããããã枬å®äžã®è©Šæãšåçã®èŒæ£
çšè©ŠæãäœæããŠçšããããšã¯å®éã«ã¯å°é£ã§ã
ãããŸããäžèšã®åŠã枬å®äžã«èŒæ£çšè©Šæãäœæ
ããŠçšãããšããŠãããã®äœæèªäœãæéã®ãã
ãæäœã§ããããã«ãèŒæ£ã«èŠããæéå
ã®è©Šæ
ã®ã°ã«ã³ãŒã¹æ¿åºŠã®å€ååã¯ããã®ãŸãŸæž¬å®èª€å·®
ãšãªã€ãŠè¡šãããŠããŸãã Furthermore, a dilution rate compensation method using a calibration sample that is considered to be the same or equivalent to the sample described above is effective if the glucose concentration in the sample can be assumed not to fluctuate during the time being calibrated. In reality, the glucose concentration usually shows economical changes during measurement, and it may change in any way, so it is necessary to prepare a calibration sample equivalent to the sample being measured. It is difficult to use in practice. Furthermore, even if a calibration sample is prepared and used during measurement as described above, the preparation itself is a time-consuming operation, and the fluctuations in the glucose concentration of the sample during the time required for calibration will result in measurement errors. It becomes apparent.
å³ã¡ãããŠãŒããã³ãã®æµéããåããŠãŒãæ¯
ã«çµæçã«å€ããå¿é
ãããã®ã§ããã®å€åãé
次è£åããããšã枬å®ã®æ£ç¢ºãã®äžã§å¿
èŠã§ãã
ããåè¿°ã®å
è¡æè¡ã«ãããèŒæ£çšè©Šæã¯æž¬å®äž
ã«é次äœæãããŠçšããããã®ã«é©åœãªãã®ã§ã¯
ãªãé次è£åã¯äžå¯èœã§ããã That is, since there is a concern that the flow rate of the tube pump may change over time for each tube, it is necessary to compensate for this change sequentially for measurement accuracy, but the calibration sample in the prior art described above It is not suitable for being created and used sequentially during measurements, and sequential compensation is not possible.
æ¬çºæã¯ããããå
è¡æè¡ãå«ãåŸæ¥æè¡ã®æ¬
ç¹ã解æ¶ãããªããããã®ã§ãããè©Šæ液ãšä»ã®
èŒæ£æ¶²ãšæµè·¯ïŒããŠãŒããã³ãïŒãå
±éã«ããè£
眮ã®èŒæ£ãé次è¡ãªãããšã«ãã€ãŠè¡ç³å€ãé·æ
éé£ç¶ããŠæ£ç¢ºã«ã¢ãã¿ãŒããè£
眮ãæäŸããã
ã®ã§ããã The present invention has been made to eliminate the drawbacks of the prior art including these prior art, and by sharing a flow path (tube pump) with the sample liquid and other calibration liquid, and by sequentially calibrating the device. The present invention provides a device that accurately monitors blood sugar levels continuously over a long period of time.
以äžãæ¬çºæãå³é¢ã«åºã¥ããŠè©³çŽ°ã«èª¬æã
ãã第ïŒå³ã¯æ¬çºæã«ä¿ãè¡æ¶²æåã®èªåé£ç¶æž¬
å®è£
眮ã®æ§æã®ïŒäŸã瀺ããããã¯å³ã§ãããæ¬
è£
眮ã¯æ¡è¡éšïŒãèŒæ£æ¶²é液éšïŒããµã³ããªã³ã°
æ©æ§ïŒãç·©è¡æ¶²é液éšïŒã枬å®éšïŒãæäœéšïŒã
ãã³æž¬å®ã»å¶åŸ¡åè·¯éšïŒçããæ§æãããã Hereinafter, the present invention will be explained in detail based on the drawings. FIG. 1 is a block diagram showing an example of the configuration of an automatic continuous measuring device for blood components according to the present invention. 4, a measurement section 5, an operation section 6, a measurement/control circuit section 7, etc.
ãŸãæ¡è¡éšïŒã¯ããã€ã¹ããŒã¶ãã«äºé管ã«ã
ãŒãã«ïŒïŒãæåè¡è¬ïŒïŒãæåè¡è¬é液çšããŠ
ãŒããã³ãP1ãæ¡è¡çšããŠãŒããã³ãP2ãæå
è¡è¬é液ããŠãŒãïŒïŒãæ¡è¡ããŠãŒãïŒïŒããæ§
æãããããããŠè¢«éšè
ïŒå³ç€ºç¥ïŒããã®è¡æ¶²
ã¯ãã«ããŒãã«ïŒïŒã®å
端éšã«ãããŠãæåè¡è¬
ïŒïŒã§åžéããæåè¡åŠçãããªããé£ç¶çã«æ¡
è¡ãããŠãè©Šæ液ã«ããïŒïŒãžé液ããããå°ã
æåè¡è¬ïŒïŒã¯ãããªã³çãççé£å¡©æ°Žã«æº¶ãã
ããã®ã§ãããè©Šæ液ã«ããïŒïŒã¯ã液éãäžå®
é以äžã«ãªããšäœåãªéã¯ãªãŒããŒãããŒããŠã
ã¬ã€ã³ãããåžžã«æ°é®®ãªäžå®éã®è©Šæ液ïŒïŒãä¿
æããããã«ãªãããŠããããŸãããŠãŒããã³ã
P1ãšP2ã¯å軞ã«é§åããããå°åè¿°ããåŠãã
ãŠãŒãïŒïŒïŒïŒïŒããã³ããŠãŒããã³ãP1ïŒP2
ã®ç¹æ§ãå®å
šã«æããããšã¯éåžžã«é£ãããã®
ã§ããã³ãP1ïŒP2ã«ããæåè¡è¬ã®é液éãšè¡
液ã®åžåŒéã®æ£ç¢ºãªæ¯çãåžéçã決å®ããã
ããæ¿åºŠæ¢ç¥ã®æšæºæ¶²ã§ããã¹ã¿ã³ããŒãïŒæ¶²ïŒ
ïŒãçšãããåžéçã®æ±ºãæ¹ã«ã€ããŠã¯åŸè¿°ã
ãããŸããæ¡è¡éšã®äž¡ããŠãŒãïŒïŒïŒïŒïŒã®åœ¢ç¶
ã«äŸåãããªãäžå®ããå€ã®åžéçãåŸãããš
ã¯ãæåè¡è¬ïŒïŒã®æ¿åºŠãé«ããŠéãå°ãªãããŠ
åžéçãïŒã«è¿ã¥ããããšã«ãã€ãŠããçšåºŠæåŸ
ã§ãããæŽã«æ¬å®æœäŸã§ã¯ãããŠãŒãïŒïŒïŒïŒïŒ
ã®ç¹æ§ãæããããã«ãã€ã¹ããŒã¶ãã«åã®äºé
管ã«ããŒãã«ãçšããŠããããå管åã®ã«ããŒã
ã«ãçšããŠãè¯ãããšã¯å¿è«ã§ããããã®å Žåã«
ã¯å管ã®å
å£ãããããªã³çã®æåè¡è¬ããŸãã¯
ç·æº¶é
µçŽ ïŒäž»ã«ãŠããããŒãŒïŒã§ã³ãŒãã€ã³ã°ã
ãããšã«ãããæ¡è¡éšã§ã®åžéçã®åé¡ã解決ã
ãããšãã§ããã First, the blood collection section 1 includes a disposable double tube catheter 11, an anticoagulant 12, a tube pump P 1 for feeding anticoagulant, a tube pump P 2 for blood sampling, a tube 13 for feeding anticoagulant, and blood sampling. It is composed of a tube 14. Blood from a subject (not shown) is continuously collected at the distal end of the catheter 11 while being diluted with an anticoagulant 12 and subjected to anticoagulation treatment, and is sent to a sample liquid cup 15. still,
The anticoagulant 12 is heparin or the like dissolved in physiological saline. When the amount of liquid in the sample liquid cup 15 exceeds a certain level, the excess amount overflows and is drained, so that a certain amount of fresh sample liquid 16 is always retained. Also tube pump
P 1 and P 2 are driven coaxially. As mentioned above, the tubes 13 and 14 and the tube pumps P 1 and P 2
It is very difficult to perfectly match the characteristics of anticoagulants, and in order to determine the exact ratio between the amount of anticoagulant pumped by pumps P1 and P2 and the amount of blood drawn, as well as the dilution rate, we need to use standards with known concentrations. standard 2 liquids 1 liquid
7 is used. How to determine the dilution rate will be described later. Furthermore, in order to obtain a dilution rate of a constant value that is not dependent on the shapes of both tubes 13 and 14 in the blood sampling section, the concentration of the anticoagulant 12 is increased and the amount is decreased to bring the dilution rate close to 1. You can expect it to some extent. Furthermore, in this embodiment, tubes 13, 14
Although a disposable double-tube catheter is used in order to have the same characteristics, it goes without saying that a single-tube catheter may also be used. Coating with an anticoagulant or fibrinolytic enzyme (mainly urokinase) can also solve the problem of dilution at the blood collection site.
èŒæ£æ¶²é液éšïŒã¯ãé次èŒæ£ã«å¿
èŠãªæšæºæ¶²ã
ãã¹ã¿ã³ããŒãïŒæ¶²ïŒïŒãšããŒã¹æ¶²ïŒïŒããããŠ
ãŒããã³ãP3ïŒP4ã«ãã倫ã
æšæºæ¶²ã«ããïŒïŒ
ããã³ããŒã¹æ¶²ã«ããïŒïŒã«é£ç¶çã«é液ããŠã
ãããã®æšæºæ¶²ã«ããïŒïŒãšããŒã¹ïŒïŒã¯ãè©Šæ
液ã«ããïŒïŒãšåæ§ã«åžžã«æ°é®®ãªäžå®éã®åã
ã®
液ã§å
ããããŠãããäœåãªæ¶²ã¯ãªãŒããŒãããŒ
ããŠåŸè¿°ã®åŠããã¬ã€ã³ããããå°æ¬å®æœäŸã§ã¯
ããŒã¹æ¶²ïŒïŒãšããŠåŸè¿°ããç·©è¡æ¶²ïŒïŒãæµçšã
ãŠããã®ã§ãç·©è¡æ¶²æºãïŒïŒããé液ããããã
ã«ãªã€ãŠããããå¥ã®ããŒã¹æ¶²æºããèšãããã
ããé液ããŠãè¯ãããšã¯å¿è«ã§ãããã¹ã¿ã³ã
ãŒãïŒæ¶²ïŒïŒã¯ãã¹ã¿ã³ããŒãïŒæ¶²æºãïŒïŒãã
é液ãããŠããããŸãå³äžïŒïŒã¯ã¹ã¿ã³ããŒã液
éãçšã®ããŠãŒããïŒïŒã¯ããŒã¹æ¶²éãçšã®ããŠ
ãŒãã§ããã The calibration liquid feeding unit 2 supplies standard liquid 21 and base liquid 22, which are standard liquids necessary for sequential calibration, to standard liquid cups 23 using tube pumps P 3 and P 4 , respectively.
and the base liquid cup 24 is continuously fed. The standard liquid cup 23 and the base 24, like the sample liquid cup 15, are always filled with fresh constant amounts of each liquid, and excess liquid overflows and is drained as described below. In this embodiment, a buffer solution 41, which will be described later, is used as the base solution 22, so the solution is delivered from the buffer solution reservoir 42, but it is also possible to provide another base solution reservoir and send the solution from there. Of course, it is good to do so. The standard 1 liquid 21 is fed from the standard 1 liquid reservoir 21. Further, in the figure, 25 is a tube for feeding the standard liquid, and 26 is a tube for feeding the base liquid.
ãµã³ããªã³ã°æ©æ§ïŒã¯ããµã³ããªã³ã°ããºã«ïŒ
ïŒãããŠãŒããã³ãP11ã®äœçšã«ãããäºã枬
å®ã»å¶åŸ¡åè·¯ïŒã§å®ããããé åºã§è©Šæ液ã«ãã
ïŒïŒãæšæºæ¶²ã«ããïŒïŒããã³ããŒã¹æ¶²ã«ããïŒ
ïŒãã液ãåžåŒããããã«ããŠãŒãïŒïŒãéããŠ
枬å®éšïŒã®ãããã«ãM2ãžé液ããããã«èšèš
ãããŠããããã®è©³çŽ°ãªäœåã¯åŸè¿°ãããå°ãå¥
ã®æŽæµæ§œãèšããŠãããããã®å Žåã«ã¯ããºã«ïŒ
ïŒã¯æŽæµæ§œã«ãæå®ã®é åºã§æµžãããããã«èšå®
ãããã The sampling mechanism 3 includes a sampling nozzle 3
1 is a tube pump P 11 which pumps sample liquid cup 15, standard liquid cup 23 and base liquid cup 2 in the order predetermined by measurement/control circuit 7.
It is designed to suck the liquid from 4 and send it to the manifold M 2 of the measuring section 5 through the knob tube 32. Its detailed operation will be described later. In addition, another cleaning tank may be provided, in which case the nozzle 3
1 are also set to be immersed in a cleaning tank in a predetermined order.
ç·©è¡æ¶²é液éšïŒã§ã¯ãç·©è¡æ¶²ïŒïŒãäºãç±äº€æ
åšïŒïŒã«éããŠææž©åããã®ã¡ããããã«ãM1
ã«ããäºåããäžæ¹ãããŒã¹æ¶²ã«ããïŒïŒãžéã€
ãŠããŒã¹æ¶²ïŒïŒãšããä»ã®äžæ¹ã¯è©Šæ液ïŒãŸãã¯
ã¹ã¿ã³ããŒãïŒæ¶²ãããŒã¹æ¶²ïŒãšã®æ··åçšãšããŠ
ãããã«ãM2ãžå€«ã
é£ç¶ããŠé液ããããå°å³
äžãP5ã¯ããŠãŒãïŒïŒãéããŠç·©è¡æ¶²ïŒïŒãç±
亀æåšïŒïŒã«éãããŠãŒããã³ããP6ã¯ããŠãŒ
ãïŒïŒãéããŠãããã«ãM2ã«ç©ºæ°ãéã蟌ã
ããŠãŒããã³ãã§ããããã®ããŠãŒããã³ãP5ïŒ
P6ã¯ãäžè¿°ããèŒæ£æ¶²é液éšïŒã®ããŠãŒããã³
ãP3ïŒP4ããã³åŸè¿°ãããã¬ã€ã³çšããŠãŒãã
ã³ãP7ãšå軞ã«é§åãããã In the buffer solution feeding section 4, the buffer solution 41 is passed through a heat exchanger 43 in advance to constant temperature, and then transferred to the manifold M1.
One part is sent to the base liquid cup 24 as the base liquid 22, and the other part is continuously sent to the manifold M2 for mixing with the sample liquid (or standard 1 liquid, base liquid). . In the figure, P 5 is a tube pump that sends the buffer solution 41 to the heat exchanger 43 through the tube 44, and P 6 is a tube pump that sends air to the manifold M 2 through the tube 45 .
P 6 is driven coaxially with the tube pumps P 3 and P 4 of the calibration liquid feeding section 2 described above and the drain tube pump P 7 described later.
次ã«æž¬å®éšïŒã«ã¯äžè¿°ããåŠããããã«ãM2
ãèšããããŠãããææž©åãããç·©è¡æ¶²ïŒïŒãç·©
è¡é液éšïŒã®ãããã«ãM1ãéã€ãŠé液ãããŠ
ããããããã«ãM2ã«ã¯ç·©è¡æ¶²ïŒïŒã®æµããå
ç¯ããããã®ç©ºæ°ãéã蟌ãŸãããã®åç¯ããã
ç·©è¡æ¶²ã«è©Šæ液ïŒïŒïŒãŸãã¯ã¹ã¿ã³ããŒãïŒæ¶²ã
ããŒã¹æ¶²ïŒã泚å
¥ããã枬å®æ¶²ãšãªã€ãŠæµããŠã
ãã空æ°åç¯ã¯ã枬å®æ¶²ã®æ¡æ£é²æ¢ãšããã·ã³ã°
å¹æãç®çãšãããã®ã§ãããæŽã«ç®¡å£ã®æŽæµå¹
æãæåŸ
ã§ããã枬å®æ¶²ã¯ããã·ã³ã°ã³ã€ã«ïŒïŒ
ãééããããšã«ãã€ãŠè»¢åæ··åãããŠã®ã¡ãäŸ
ãã°GODåºå®åèãšéé
žåæ°ŽçŽ é»æ¥µã®çµåãã
ã«ãããªãã°ã«ã³ãŒã¹æ¿åºŠæž¬å®çšã®åºå®åé
µçŽ è
é»æ¥µïŒïŒã«éãããã°ã«ã³ãŒã¹æ¿åºŠã枬å®ãã
ãããã®å Žåãé»æ¥µïŒïŒã«ã¯æ°èãè±æ³¡ãããã
ãšãªã空æ°å±€ãšæž¬å®æ¶²å±€ã亀äºã«äžŠãã§æµãã空
æ°åç¯ãé»æ¥µïŒïŒãå«ãå
šãŠã®æž¬å®ç³»ãæŽæµããª
ãã枬å®ãç¶ãããããã®ã§ãå枬å®æ¶²ã®çžäºæ±
æã極å°åãããã枬å®ãçµã€ã液ããã³æ°æ³¡
ã¯ããã¬ã€ã³ã«ããïŒïŒãä»ããŠãã¬ã€ã³çšããŠ
ãŒããã³ãP7ã«ãããã¬ã€ã³ãã«ãïŒïŒãžãšæ
åºãããããã®ãã¬ã€ã³ã«ããïŒïŒã«ã¯ãå
è¿°ã
ãåã«ããïŒïŒïŒïŒïŒïŒïŒïŒããªãŒããŒãããŒã
ãå液ããè©Šæ液ãªãŒããŒãããŒçšããŠãŒãïŒ
ïŒãåããŠãŒããã³ãP8ãã¹ã¿ã³ããŒãïŒæ¶²ãª
ãŒããŒãããŒçšããŠãŒãïŒïŒãåããŠãŒããã³ã
P9ãããŒã¹æ¶²ãªãŒããŒãããŒçšããŠãŒãïŒïŒã
åããŠãŒããã³ãR10ã«ãã€ãŠé液ãããåãã
ãã¬ã€ã³ãã«ãïŒïŒãžãã¬ã€ã³ããããå°ãäžèš
åããŠãŒããã³ãP8ïŒP9ïŒP10ãšãµã³ããªã³ã°çš
ããŠãŒããã³ãP11ã¯å軞ã«é§åãããã Next, the measuring section 5 is equipped with a manifold M2 as described above.
A constant temperature buffer solution 41 is sent through the manifold M 1 of the buffer solution delivery section 4 . Air is also sent into the manifold M2 to divide the flow of the buffer solution 41, and the sample solution 16 (or standard 1 solution,
The base liquid) is injected and flows as the measurement liquid. The purpose of the air segment is to prevent the measurement liquid from spreading and provide a mixing effect, and can also be expected to have a cleaning effect on the tube wall. The measuring liquid is mixed in the mixing coil 51.
After being inverted and mixed by passing through, for example, it is sent to an immobilized enzyme membrane electrode 52 for measuring glucose concentration, which is a combination of a GOD immobilized membrane and a hydrogen peroxide electrode, and the glucose concentration is measured. In this case, an air layer and a measurement liquid layer flow alternately through the electrode 52 without defoaming, and measurement can be continued while the air segment cleanses the entire measurement system including the electrode 52. Mutual contamination of each measurement liquid is minimized. The liquid and air bubbles that have been measured are discharged via the drain cup 53 to the drain bolt 54 by the drain tube pump P7 . The drain cup 53 also contains the liquids that have overflowed the cups 15, 23, and 24 described above from the sample liquid overflow tube 1.
8. Same tube pump P 8 , standard 1 liquid overflow tube 27, same tube pump
P 9 , base liquid overflow tube 28,
The liquid is sent by the same tube pump R 10 and drained to the drain bolt 54 as well. The tube pumps P 8 , P 9 , P 10 and the sampling tube pump P 11 are coaxially driven.
æäœéšïŒã¯ãè£
眮ã®æäœå
šãŠãåžã©ã€ãŠããã
æäœã¹ã€ããïŒïŒãããŒããŒãïŒïŒã«ããè£
眮ã®
æäœãè¡ãªãããã The operation unit 6 controls all operations of the device,
The device is operated using an operation switch 61 and a keyboard 62.
æåŸã«æž¬å®ã»å¶åŸ¡åè·¯éšïŒã¯ãâå€æåšïŒ
ïŒãâå€æåšïŒïŒããã€ã¯ãã³ã³ããŠãŒã¿ãŒ
ïŒïŒããã³è¡šç€ºåšïŒïŒããæããã°ã«ã³ãŒã¹é»æ¥µ
ïŒïŒããã®åºåä¿¡å·ãåŠçããé次èŒæ£ããåŸã®
è¡ç³å€ã衚瀺åšïŒïŒã«é次衚瀺ãããšãšãã«ããµ
ã³ããªã³ã°æ©æ§ïŒã®åäœã®å¶åŸ¡ãè¡ãªã€ãŠããã Finally, the measurement/control circuit section 7 includes an IV converter 7
1. Consists of an A-D converter 72, a microcomputer 73, and a display 74, which processes the output signal from the glucose electrode 52 and sequentially displays the blood glucose level after sequential calibration on the display 74. The operation of the robot is controlled.
次ã«ãæäœæé ã«åŸã€ãŠæ¬çºæã説æããã Next, the present invention will be explained according to the operating procedure.
ãŸããåèŒæ£æ¶²çãæºåãããã®ã¡ãæäœéšïŒ
ã®é»æºã¹ã€ããSWãå
¥ããå
šãŠã®ããŠãŒããã³
ãP1ãP11ãäœåãããããŒããŒãïŒïŒã§æ¥ä»ã
çªå·çããã€ã¯ãã³ã³ããŠãŒã¿ãŒïŒïŒã«å
¥åãã
ããæå®ã®ãŠãªãŒã ã¢ãããå®äºãããšãæäœã¹
ã€ããïŒïŒã®ã¹ã¿ã³ããŒãã¹ã€ããïŒïŒïŒãç¹ç¯
ãããã³ãã¹ã€ããïŒïŒïŒãæ¶ç¯ããŠåãã³ãã¯
åæ¢ããã次ãã§CALBã¹ã€ããïŒïŒïŒãæŒããš
åã³åãã³ãã¯é転ãéå§ãããµã³ããªã³ã°æ©æ§
ïŒãäœåãã¯ããããã«ããŒãã«ïŒïŒãã¹ã¿ã³ã
ãŒãïŒæ¶²ïŒïŒã«æ¿å
¥ãã液ïŒïŒãåžå
¥ããŠããè©Š
æ液ã«ããïŒïŒã«æµå
¥ãããŸã§ã«èŠããé
ãæé
ãã¹ããããŠãªããçã§èšæãããã®æéãããŒ
ããŒãïŒïŒããå
¥åããŠåŸã®æž¬å®ã«çšãããé
ã
æéã¯ãã«ããŒãã«ã®ä»æ§ãå€ããªãéãïŒã¿ã€
ãããã³ããŠãŒãé·ãã®å€æŽããªãéãïŒå®è³ªç
ã«äžå®ã§ãããšèŠåããã®ã§ãäžåºŠæž¬å®ããã°ã
ãã®åŸã®ã«ããŒãã«äº€ææã«ãããŠã¯ããã®å€ã
ããå
¥åããã°ãããåŒãç¶ããæ¿åºŠæ¢ç¥ã§ãã
ã¹ã¿ã³ããŒãïŒæ¶²ïŒïŒãè©Šæ液ã®ä»£ãã«æž¬å®ãã
æ¡è¡éšïŒã§ã®è¡æ¶²ãšæåè¡è¬ïŒïŒãšã®åžéçã決
å®ããŠãã€ã¯ãã³ã³ããŠãŒã¿ãŒïŒïŒã«èšæ¶ããã
以åŸã®æž¬å®ã«çšãããæ¡è¡ïŒã§ã®åžéçã®æž¬å®
ã¯ãæåè¡è¬ãå
å£ã«ã³ãŒãã€ã³ã°ããå管åã®
ã«ããŒãã«ãçšããããšãªã©ã«ããçç¥ããããš
ãã§ããã First, after preparing each calibration solution, etc.,
Turn on the power switch SW, operate all tube pumps P 1 to P 11 , and enter the date, number, etc. into the microcomputer 73 using the keyboard 62. When the predetermined warm-up is completed, the standard switch 612 of the operation switch 61 lights up, the pump switch 611 goes out, and each pump stops. Next, when the CALB switch 613 is pressed, each pump starts operating again, and the sampling mechanism 3 also starts operating. Insert the catheter 11 into the standard 2 liquid 17, measure the delay time required from inhaling the liquid 17 until it flows into the sample liquid cup 15 using a stopwatch, etc., and input this time from the keyboard 62 for later measurements. use Once measured, the lag time can be assumed to be essentially constant unless the catheter specifications change (unless the type and tube length change).
When replacing the catheter thereafter, only that value needs to be input. Subsequently, standard 2 liquid 17 of known concentration was measured instead of the sample liquid,
Determining the dilution rate of the blood and anticoagulant 12 in the blood collection section 1 and storing it in the microcomputer 73,
Used for subsequent measurements. The measurement of the dilution rate in blood collection 1 can also be omitted by using a single-tube catheter whose inner wall is coated with an anticoagulant.
ã«ããŒãã«ïŒïŒãæ£è
ã«ã»ãããããšãè¡æ¶²ã
äžèšåžéçã«ãŠåžéããããšãšãã«æåè¡åŠçã
ããè©Šæ液ã«ããïŒïŒã«é£ç¶çã«é液ããããã«
ããïŒïŒã®è©Šæ液ïŒïŒã®æ¶²éãäžå®é以äžã«ãªã
ãšãäœåãªæ¶²ã¯ãªãŒããŒãããŒããŠãã¬ã€ã³ãã«
ãïŒïŒãžæåºãããã«ããïŒïŒå
ã«ã¯åžžã«äžå®é
ã®æ°é®®ãªè©Šæ液ïŒïŒãä¿æãããæ§é ã«ãªã€ãŠã
ããåŸã€ãŠãããºã«ïŒïŒãè©Šæ液ïŒïŒãã¹ã¿ã³ã
ãŒãïŒæ¶²ïŒïŒããã³ããŒã¹æ¶²ïŒïŒãé 次繰ãè¿ã
åžåŒãããããã®éã®çžäºæ±æã¯åé¿ãããã When the catheter 11 is set in the patient, the blood is diluted at the above-mentioned dilution rate, anticoagulated, and continuously fed into the sample liquid cup 15. When the amount of sample liquid 16 in cup 15 exceeds a certain level, the excess liquid overflows and is discharged to drain bolt 54, so that a certain amount of fresh sample liquid 16 is always retained in cup 15. It's summery. Therefore, although the nozzle 31, the sample liquid 16, the standard 1 liquid 31, and the base liquid 22 are repeatedly sucked in sequence, mutual contamination is avoided.
次ã«ããšãã¯ã¹ã€ããïŒïŒïŒãæŒããšãæ£è
ã®
è¡ç³å€ãé£ç¶çã«æž¬å®ãããã Next, when the check switch 614 is pressed, the patient's blood sugar level is continuously measured.
å
ãããµã³ããªã³ã°ããºã«ïŒïŒã¯æšæºæ¶²ã«ãã
ïŒïŒããäžå®éã®ã¹ã¿ã³ããŒãïŒæ¶²ïŒïŒãæå®ã®
æ¹åŒã§åžå
¥ãããäŸãã°ã第ïŒå³ã®åŠã空æ°ç¯å
ã§ïŒã€ã«åããããç¶æ
ã§20ç§éåžå
¥ããã次ã
ã§ããºã«ïŒïŒã¯ããŒã¹æ¶²ã«ããïŒïŒã«ç§»ãæå®ã®
ç¶æ
ãäŸãã°ç¬¬ïŒå³ã®åŠã空æ°åç¯ã§ïŒã€ã«åã
ãããç¶æ
ã§40ç§éããŒã¹æ¶²ïŒïŒãåžå
¥ããã次
ã«ãããºã«ïŒïŒã¯è©Šæ液ã«ããïŒïŒã«å
¥ãããæ
å®ã®æ¹åŒäŸãã°ç¬¬ïŒå³ã®åŠãã¹ã¿ã³ããŒãïŒæ¶²ïŒ
ïŒã®å Žåãšåæ§ã«ç©ºæ°åç¯ã§ïŒã€ã«åããããç¶
æ
ã§20ç§éè©Šæ液ïŒïŒãåžå
¥ãããæŽã«ããºã«ïŒ
ïŒã¯ããŒã¹æ¶²ã«ããïŒïŒã«å
¥ãããåèšåæ§ã®æ
äœã§40ç§éããŒã¹æ¶²ïŒïŒã«åžå
¥ããããã®åŸãã
ãã«ïŒïŒã¯åã³æšæºæ¶²ã«ããïŒïŒã«å
¥ãããåèš
åäœåç¹°ãè¿ããå°ã第ïŒå³äžãAIRã¯ç©ºæ°å
ç¯ãSTDãBASEãSAMã¯å€«ã
äžèšç©ºæ°åç¯ã§
åããããã¹ã¿ã³ããŒãïŒæ¶²ïŒïŒãããŒã¹æ¶²ïŒ
ïŒãè©Šæ液ïŒïŒã®æ¶²æ³¡ã瀺ãããŸã空æ°åç¯ã¯ã
ãºã«ïŒïŒãå液ã«åºå
¥ãããããšã«ããé©å®å€§ã
ãã®ãã®ãä»»æééãä»»æåæ°äœãããšãã§ã
ãã First, the sampling nozzle 31 sucks a certain amount of standard 1 liquid 21 from the standard liquid cup 23 in a predetermined manner. For example, as shown in Figure 2, inhale for 20 seconds with the air divided into two parts. Next, the nozzle 31 moves to the base liquid cup 24 and sucks in the base liquid 22 for 40 seconds in a predetermined state, for example, in a state in which the air is divided into eight air segments as shown in FIG. Next, the nozzle 31 enters the sample liquid cup 15 and performs standard 1 liquid 2 in a predetermined manner, for example, as shown in FIG.
As in case 1, the sample liquid 16 is inhaled for 20 seconds while being divided into two by the air segment. Furthermore, nozzle 3
1 enters the base liquid cup 24 and sucks it into the base liquid 22 for 40 seconds using the same action as described above. Thereafter, the knob 31 enters the standard solution cup 23 again and repeats the above operating circle. In Figure 2, AIR is the air segment, and STD, BASE, and SAM are the standard 1 liquid 21 and base liquid 2, which are separated by the above air segment.
2. The bubbles of the sample liquid 16 are shown, and air segments of an appropriate size can be created at arbitrary intervals and in any number by moving the nozzle 31 in and out of each liquid.
ãã®ããºã«ïŒïŒã®ç§»åã¯ãäŸã第ïŒå³ïœïŒïœã«
瀺ãåŠããµã³ããªã³ã°æ©æ§ïŒã«ããè¡ãªãããã
ãŸããããºã«ïŒïŒã¯ããºã«ã¢ãŒã å
端éšïŒïŒïœã®
åçŽéåïŒïŒïŒã«åµæ¿åºå®ããããã®äžéšã«ã¯ãµ
ã³ããªã³ã°çšããŠãŒããã³ãP11ã«é£ãªãããºã«
ããŠãŒãïŒïŒãåµèŸŒãããŠãããäžæ¹ãããºã«ã¢
ãŒã ïŒïŒã¯ããã®åŸç«¯éšïŒïŒïœã®åŽéšã«èšããé·
åïŒïŒïŒã«æšªåµããæ¯è»žïŒïŒïŒãšãããºã«ã¢ãŒã
å
端éšåŽæ¹ã«çªèšãããã³ïŒïŒïŒãæ¯æ¿ããåæ¿
ïŒïŒïŒã«ããæ¯æãããããã®ãã³ïŒïŒïŒã¯ãå
æ¿ïŒïŒïŒã®åšçžéšïŒå³ã§ã¯å·Šç«¯ïŒã®éåïŒïŒïŒã«
éåµããã該åæ¿ïŒïŒïŒãã¢ãŒã¿ãŒïŒïŒïŒã«ã
ããããè§åºŠäŸãã°180床ååããã«åŸã€ãŠãã
ã³ïŒïŒïŒã«é£ãªãããºã«ã¢ãŒã å
端éšïŒïŒïœã第
ïŒå³ïœã®åŠãå匧ç¶ã«ååŸåããããå³ã¡ããã®
åæ¿ïŒïŒïŒã®ååã«ãããããºã«ïŒïŒããã³ããº
ã«ã¢ãŒã ïŒïŒãå®ç·äœçœ®ãšç Žç·äœçœ®ãåŸåŸ©ããã
ãºã«ïŒïŒã¯å®ç·äœçœ®ã«ããå Žåã«ããŒã¹æ¶²ã«ãã
ïŒïŒã«ããŸãç Žç·äœçœ®ã«ããå Žåã«æšæºæ¶²ã«ãã
ïŒïŒããã³è©Šæ液ã«ããïŒïŒã«å€«ã
æ¿å
¥ãããã
å°ãæšæºæ¶²ã«ããïŒïŒãšæž¬å®è£
眮ã«ããïŒïŒã¯ã¹
ã©ã€ãããŒã¹ïŒïŒäžã«èŒçœ®ããã該ã¹ã©ã€ãããŒ
ã¹ïŒïŒã¯ã¢ãŒã¿ïŒïŒïŒã«ããå転ãããåå¿ã«ã
ïŒïŒïŒããã³ã¹ããªã³ã°ïŒïŒïŒãŸãã¯ã©ãã¯ãšã
ããªã³ïŒå³ç€ºç¥ïŒã«ããååŸåããŠãäž¡ã«ããïŒ
ïŒïŒïŒïŒãé 次åžåŒäœçœ®ãæã€ãŠããããããã¢
ãŒã ïŒïŒããã³ã¹ã©ã€ãããŒã¹ïŒïŒã®åãã¯ãã€
ã¯ãã³ã³ããŠãŒã¿ãŒïŒïŒã«ãã€ãŠå¶åŸ¡ãããŠã
ããããºã«ã¢ãŒã ïŒïŒã®é§åã¯ãäžèšã®ä»ã«ãã
ãªããã€ã¯ãã»ã³ãµãŒãšã¹ãããã³ã°ã¢ãŒã¿ã®çµ
åããªã©ã®é»æ°çãæ©æ¢°çãªæ段ã§åæ¿ïŒïŒïŒã
ååããããã®ãèããããã This movement of the nozzle 31 is performed by a sampling mechanism 3 as shown in FIGS. 3a and 3b, for example.
First, the nozzle 31 is fitted and fixed into a vertical through hole 331 of the nozzle arm tip 33a, and a nozzle tube 32 connected to the sampling tube pump P11 is fitted into the upper part of the nozzle 31. On the other hand, the nozzle arm 33 is supported by a support shaft 333 fitted laterally into a long hole 332 provided on the side of the rear end 33b, and a disk 335 that supports a pin 334 protruding from the side of the tip of the nozzle arm. Ru. This pin 334 is loosely fitted into a through hole 336 at the peripheral edge of a disc 335 (the left end in the figure), and as the disc 335 is rotated by a certain angle, for example, 180 degrees, by a motor 337, the pin 334 is connected to the pin 334. The nozzle arm tip 33a is moved back and forth in an arc as shown in FIG. 3a. That is, due to the rotation of this disk 335, the nozzle 31 and the nozzle arm 33 reciprocate between the solid line position and the broken line position, and the nozzle 31 is applied to the base liquid cup 24 when it is in the solid line position, and to the standard liquid cup 24 when it is in the broken line position. They are inserted into the liquid cup 23 and the sample liquid cup 15, respectively.
The standard liquid cup 23 and measuring device cup 15 are placed on a slide base 34, and the slide base 34 is moved back and forth by an eccentric cam 341 and a spring 342 rotated by a motor 343 or by a rack and pinion (not shown). , both cups 2
3 and 15 are sequentially brought to the suction position. The movements of these arms 33 and slide base 34 are controlled by a microcomputer 73. In addition to the above-described method, the nozzle arm 33 may be driven by electrical or mechanical means such as a combination of a photomicro sensor and a stepping motor, which rotates the disk 335.
次ã«æ¬å®æœäŸã§ã¯ã第ïŒå³ãããããããã
ã«ãïŒã€ã®æž¬å®ãµã€ã¯ã«ã«ïŒåãèŠããŠãããå³
ã¡æ¬çºæã¯ãå³å¯ãªæå³ã§ã¯è©Šæ液ãé£ç¶ããŠæž¬
å®ããŠããªãããè©Šæ液äžã®è¡ç³å€ã¯ã第ïŒå³ã«
ãã®ïŒäŸã瀺ãåŠãããªãæ»ããã«å€åãããã®
ã§ããããã®çšåºŠã®æéééã§æ¥æ¿ã«å€åããã
ãšã¯ãªããïŒåééã§ã®æž¬å®ã§ååã«é£ç¶ãšåç
ã®æ矩ãæãã枬å®ãã§ãããã®ã§ããããŸãæ¬
çºæã¯ã枬å®ãµã€ã¯ã«ãïŒåééã§ããããšèªäœ
ã«ç¹åŸŽãæãããã®ã§ã¯ãªãããã®åšæãããç
ããããããã¯ããé·ãããŠãè¯ãããšã¯å¿è«ã§
ããã Next, in this example, as can be seen from FIG. 2, one measurement cycle requires two minutes. That is, although the present invention does not measure the sample liquid continuously in a strict sense, the blood sugar level in the sample liquid changes fairly smoothly as shown in FIG. There is no sudden change in the time interval of 2 minutes, and measurement at 2 minute intervals is sufficient to carry out measurements equivalent to continuous measurement. Furthermore, the present invention is not characterized by the fact that the measurement cycle is at 2-minute intervals; it goes without saying that this cycle may be shorter or longer.
以äžã®åŠãããŠåŸãããäŸãã°ç¬¬ïŒå³ã«ç€ºãã¹
ã¿ã³ããŒãïŒæ¶²ïŒïŒãããŒã¹æ¶²ïŒïŒããã³è©Šæ液
ïŒïŒã®æµãã¯ãå
šãåäžã®æµè·¯å³ã¡ããºã«ããŠãŒ
ãïŒïŒãéã€ãŠãããã«ãM2ãžé液ããããã
ã§å液ã¯ææž©åãããç·©è¡æ¶²ïŒïŒã«ãŠåæ§ã«åžé
ããã空æ°å±€ã«ãã€ãŠå解ããã倫ã
ã¹ã¿ã³ããŒ
ã液çšæž¬å®æ¶²ãããŒã¹æ¶²çšæž¬å®æ¶²ãããã³è©Šæ液
çšæž¬å®æ¶²ãšãªã€ãŠããã·ã³ã°ã³ã€ã«ïŒïŒãžéãã
ãŠããã該ããã·ã³ã°ã³ã€ã«ïŒïŒã§æ··ååäžåã
ããå枬å®æ¶²ã¯ã空æ°å±€ã«ãã€ãŠåç¯ããããŸãŸ
ã°ã«ã³ãŒã¹é»æ¥µïŒïŒãžãšé 次æµå
¥ããåã
ã®æž¬å®
液ã®æž¬å®ããªãããã For example, the flows of standard 1 liquid 21, base liquid 22 , and sample liquid 16 shown in FIG. Here, each solution is similarly diluted with a constant-temperature buffer solution 41, decomposed by an air layer, and mixed into a measurement solution for the standard solution, a measurement solution for the base solution, and a measurement solution for the sample solution. It is sent to the coil 51. Each measurement liquid mixed and homogenized by the mixing coil 51 sequentially flows into the glucose electrode 52 while being divided by an air layer, and each measurement liquid is measured.
ãããŠãé»æ¥µïŒïŒããã®ä¿¡å·ã¯ãâå€æåš
ïŒïŒãâå€æåšïŒïŒãä»ããŠãã€ã¯ãã³ã³ã
ãŠãŒã¿ãŒïŒïŒã«è³ãããããã®ä¿¡å·ã¯ãåã
ã¹ã¿
ã³ããŒãïŒæ¶²ïŒïŒã®æž¬å®å€å³ã¡æšæºå€ãšãããŒã¹
液ïŒïŒã®æž¬å®å€å³ã¡ããŒã¹å€ãšãè©Šæ液ïŒïŒã®å€
å³ã¡è©Šéšå€ãè¡šãããŠããããããã®ïŒã€ã®æž¬å®
å€ã¯ãããºã«ïŒïŒä»¥éã®å
šãŠæž¬å®æµè·¯ã«ãããŠã
å液ïŒïŒïŒïŒïŒïŒïŒïŒãå
šãåäžã®æµè·¯ãéãã
åãæ§ã«åžéãã枬å®ãããå€ã§ããããšã«æ³šç®
ãã¹ãã§ãããå³ã¡ãåè¿°ã®åŠãããŠãŒããã³ã
ãçšããæµè·¯ã«ãããŠã¯ãæµãã®ç¶æ
ãçµæçã«
å€åããããšãæ®éã«èµ·ããããããã§ã¯ïŒæ¶²ïŒ
ïŒïŒïŒïŒïŒïŒïŒã®æµè·¯ãå
šãåäžã§ããããšã«ã
ããæµè·¯ïŒå³ã¡ããºã«ããŠãŒãïŒïŒïŒã®æµãã®ç¶
æ
ã®å€åã¯äºãã«æã¡æ¶ãåã€ãŠããã®åœ±é¿ãè£
åã§ãããè©Šæ液ãšèŒæ£æ¶²ãšã®æµè·¯ãå¥ã
ã«ããŠ
å Žåã«ã¯æµãã®ç¶æ
ã®å€åãè£åãåŸãªãããšã¯
åè¿°ã®éãã§ããã The signal from the electrode 52 then reaches a microcomputer 73 via an IV converter 71 and an AD converter 72. These signals represent the measured value of the standard 1 liquid 21, that is, the standard value, the measured value of the base liquid 22, that is, the base value, and the value of the sample liquid 16, that is, the test value, respectively. These three measured values are obtained in all measurement channels after the nozzle 31.
Each liquid 21, 22, 16 passes through the same flow path,
It should be noted that the values were similarly diluted and measured. That is, as mentioned above, in a flow path using a tube pump, it is common for the flow state to change over time, but in this case, three liquids, two
Since the flow paths 1, 31, and 16 are exactly the same, changes in the flow conditions of the flow paths (ie, nozzle tube 32) can cancel each other out and compensate for their effects. As mentioned above, if the flow paths for the sample liquid and the calibration liquid are separated, changes in flow conditions cannot be compensated for.
ããã§ãé»æ¥µïŒïŒããã®åºåä¿¡å·ãçšããŠè¡ç³
å€ãç®åºããæ¹åŒã«ã€ã第ïŒå³ãçšããŠèª¬æã
ãã Here, a method for calculating the blood sugar level using the output signal from the electrode 52 will be explained using FIG.
暪軞ã¯æéã§ããã瞊軞ã¯é»æ¥µïŒïŒããã®åºå
ïŒãã詳ããã¯åºåã®ç§»åå¹³åã«ãŠã³ãæ°ïŒã§ã
ãã第ïŒå³äžïŒ³ïŒã¯ã¹ã¿ã³ããŒãïŒæ¶²ã枬å®ãã
æã®æ倧å€ã§ãããSBã¯è©Šæ液ã枬å®ããæã®
æ倧å€ãã¯ã¹ã¿ã³ããŒãïŒæ¶²ã®çŽåŸã®ããŒã¹æ¶²
ã枬å®ããæã®æå°å€ãè¡šãããŠãããå
è¿°ãã
æ¡è¡éšïŒã§ã®åžéçã第ïŒå³ã«åºã¥ã説æãã
ãšã
ïŒS2âïŒS1âÃC1ïŒC2ã§è¡šãããããã®ã§ãã
ã
ããã§S2ã¯ã¹ã¿ã³ããŒãïŒæ¶²ïŒïŒãããæã®æ
倧å€ãC1ããã³C2ã¯å€«ã
ã¹ã¿ã³ããŒãïŒæ¶²ãã
ã³ïŒæ¶²ã®æ¿åºŠã§ããå
±ã«æ¢ç¥ã§ããã The horizontal axis is time, and the vertical axis is the output from the electrode 52 (more specifically, the moving average count number of the output). In Figure 5, S1 is the maximum value when measuring the standard 1 solution, SB is the maximum value when measuring the sample solution, and B is the minimum value when measuring the base solution immediately after the standard 1 solution. ing. The dilution rate D in the blood collection section 1 mentioned above is explained based on FIG . The maximum values, C 1 and C 2 , are the concentrations of standard solution 1 and solution 2, respectively, and are both known.
è©Šæ液è¡ç³å€ïŒ¢ã»ïŒ§ã¯ããã®çŽåã®S1ã®å€ã
ãã³ïŒ¢ã®å€ãçšããŠè¡šããããæ£å³ã®è©Šéšå€
SBâãçŽåã®æ£å³ã®æšæºå€S1âã®ã©ã®äœã®
å²åãã«åºã¥ããŠæ±ºå®ããããå³ã¡
ã»ïŒ§ïŒïŒïŒïŒ€ÃSBâïŒS1âÃC1ã§ããã The sample liquid blood sugar level B/G is expressed using the value of S1 and the value of B just before this, and the net test value
SB-B is determined based on the percentage of the previous net standard value S1-B. That is, B.G=1/DÃSBâB/S1âBÃ C1 .
å°ã枬å®ã«çšããS1ããã³ïŒ¢ã®å€ã¯ãå¥ã®æ±
ãæ¹äŸãã°ç¬¬ïŒå³ã«ãããŠè©Šéšå€ã®çŽåã®ïŒ¢å€ãš
çŽåŸã«S1å€ãçšããŠç®åºããããã«ããŠãããã
ãã ãããŠãŒããã³ããçšããå Žåã«ã¯æµãã®ç¶
æ
ãçµæçã«å€åããããšãæ®éãªã®ã§ãé次ã
枬å®ã®ã¹ãã³å³ã¡S1âãèŒæ£ããå¿
èŠãããã
çšããS1å€åã³ã³ïŒ¢å€ã¯ã枬å®å¯Ÿè±¡ä¿¡å·ã§ãã
SBã«è¿æ¥ããåæã®ãã®ãçšããããšãæå©ã§
ããããšã¯æããã§ããã The values of S1 and B used in the measurement may be calculated using another method, for example, using the B value immediately before the test value and the S1 value immediately after the test value in FIG.
However, when using a tube pump, it is normal for the flow condition to change over time, so
It is necessary to calibrate the span of measurement, i.e. S1-B,
The S1 value and B value used are the signals to be measured.
It is clear that it is advantageous to use a location close to the SB.
æ¬çºæã§ã¯ã以äžã®åŠãé次èŒæ£ããŠããã®
ã§ãæµè·¯ã®æµãã®ç¶æ
ãå€åããŠããã®åœ±é¿ãå
ãã«ãããã®ã§ããããŸãããã®é次èŒæ£ããã¹
ã¿ã³ããŒãïŒæ¶²ãšããŒã¹æ¶²ã®ïŒçš®ã®èŒæ£æ¶²ãçš
ããäžã€ãããèŒæ£æ¶²ãšè©Šæ液ãå
šãåäžã®æµè·¯
ãæµããŠãããã極ããŠæå¹ãªãã®ã§ããã In the present invention, since the calibration is performed sequentially as described above, it is less affected by changes in the flow state of the channel, and the sequential calibration is also performed using two types of standard liquid and base liquid. This method is extremely effective because it uses the same calibration solution and the calibration solution and sample solution flow in exactly the same flow path.
ããããŠãé次ãäŸãã°ïŒåæ¯ã«æž¬å®ãããè©Š
æ液ã®è¡ç³å€ã¯ã衚瀺åšïŒïŒã«ãäŸãã°ç¬¬ïŒå³ã®
åŠãæ£ã°ã©ãç¶ã«è¡šç€ºãããïŒSTARTã¢ãŒãïŒã
ããã§çžŠè»žã¯æéã暪軞ã¯è¡ç³æïŒBLOOD
GLUCOSEïŒmgïŒd1ïŒïŒã§ããã In this way, the blood glucose level of the sample liquid measured sequentially, for example every two minutes, is displayed on the display 74 in the form of a bar graph as shown in FIG. 6, for example (START mode).
Here, the vertical axis is time, and the horizontal axis is blood sugar charge (BLOOD
GLUCOSE (mg/d1)).
å°ãæäœã¹ã€ããïŒïŒã«ã¯ãã¹ã¿ãŒãã¹ã€ãã
ïŒïŒïŒãèšããããŠãããåçš®ã®è² è·è©Šéšã«çšã
ãã®ã«é©ããŠãããäŸãã°OGTTïŒçµå£ç³è² è·è©Š
éšïŒæž¬å®ã®å Žåãç³è² è·ã®éå§æã«ã¹ã¿ãŒãã¹ã€
ããïŒïŒïŒãONã«ãããšããã®æããèšæãã
枬å®ã¯åèšããšãã¯ã¹ã€ããïŒïŒïŒã®å Žåãšåæ§
ã«é²ãããã枬å®å€ãæéçµéãšå
±ã«åŸãããã
ãŸããããŒããŒãïŒïŒã«ãããOGTTã¢ãŒãã§
ã®æž¬å®çµæ衚瀺ãæå®ãããšãç³è² è·åŸ30ååŸã®
è¡ç³å€ã60ååŸã®è¡ç³å€ã90ååŸã®è¡ç³å€ã120
ååŸã®è¡ç³å€ãšããå®æéåœãã®è¡ç³å€ã¯å¿è«ã
ïŒåæ¯ã®è¡ç³å€ãïŒæéã«ãããå
šè¡ç³éã22æ
éå
ã®æé«æ¿åºŠå€ãšãã®åºçŸæéããïŒæéã®æž¬
å®çµäºã®åŸè¡šç€ºãããã第ïŒå³ã¯ãã®ïŒäŸã§ãã
ïŒç¬¬ïŒå³ã®ãã®ãšã¯å¥æ€åïŒãå°ã第ïŒå³ã®ã°ã©ã
ããæé軞ãçããããŠè¡šç€ºãããã®ã第ïŒå³ã§
ããã第ïŒå³ã«æ¯ã¹ãŠããŒã¯ãå€ãããããã第
ïŒå³ã®ã°ã©ãã第ïŒå³ã®ã°ã©ãã«ä»£ããŠãããã
ã¯äžŠè¡ããŠè¡šç€ºãããããšãã§ããã Note that the operation switch 61 is also provided with a start switch 615, and is suitable for use in various load tests. For example, in the case of OGTT (oral glucose tolerance test) measurement, if the start switch 615 is turned on at the beginning of glucose tolerance, the time will start from this time.
Measurement proceeds in the same manner as with the check switch 614, and measured values are obtained over time.
In addition, if you specify the measurement result display in OGTT mode using the keyboard 62, the blood sugar level 30 minutes after glucose loading, the blood sugar level 60 minutes later, the blood sugar level 90 minutes later, 120
Of course, the blood sugar level per minute, which is the blood sugar level per actual time,
The blood sugar level every 2 minutes, the total blood sugar amount for 2 hours, the highest concentration value within 22 hours and its appearance time are displayed after 2 hours of measurement. Figure 4 is an example (before the separate examination from Figure 6). In addition, Figure 7 is a representation of the graph in Figure 4 with the time axis shortened, and although the peaks are easier to see than in Figure 4, it is possible to replace the graph in Figure 7 with the graph in Figure 4. , or can be displayed in parallel.
é»æ¥µã§æž¬å®ãçµãã液ããã³æ°æ³¡ã¯ããã¬ã€ã³
ã«ããïŒïŒãä»ããŠãã¬ã€ã³ãã«ãïŒïŒãžæ液ã
ããããã¬ã€ã³ãã«ãïŒïŒã«ã¯åã«ããïŒïŒïŒïŒ
ïŒïŒïŒïŒããªãŒããŒãããŒããå液ããã¬ã€ã³ã
ããããšã¯äžè¿°ã®éãã§ããã The liquid and bubbles that have been measured by the electrodes are drained to the drain bolt 54 via the drain cup 53. Each cup 15, 2 is attached to the drain bolt 54.
As described above, the liquids that overflowed through 3 and 24 are also drained.
äžé£ã®æž¬å®ãçµäºãããšã¹ãããã¹ã€ããïŒïŒ
ïŒãæŒãããšã«ããè£
眮ã®é転ã¯åæ¢ããã When the series of measurements is completed, the stop switch 61
Pressing 6 stops the operation of the device.
以äžã®åŠããæ¬çºæãå®æœåããŠãªãè¡ç³ã®èª
åé£ç¶æž¬å®è£
眮ã¯ãè©Šæ液ãé£ç¶ããŠæµãããŸãŸ
ã§è©Šæ液ãæšæºæ¶²ãããŒã¹æ¶²ãé 次繰ãè¿ããŠãµ
ã³ããªã³ã°ããããããå
šãåäžã®æµè·¯ãæµããŠ
é次èŒæ£ããªãã枬å®ãããã®ã§ãããšããã
ããããŠãŒããã³ãã«ç¹åŸŽçãªæµãã®ç¶æ
ã®å€å
ã®åœ±é¿ãåããã«ãè¡ç³å€ããã³ãã®å€åãã¿ãŒ
ã³ãèªåçãé£ç¶çäžã€æ£ç¢ºã«æž¬å®ããããšå¯èœ
ãšãããã®ã§ãããæŽã«å液ã¯ç©ºæ°å±€ã§åç¯ãã
ãªããæµãããã®ã§çžäºæ±æããªããåºå®åé
µçŽ
èé»æ¥µãçšãããè±æ³¡è£
眮ãäžèŠã§è£
眮ãç°¡çŽ å
ãããè©Šæ液ã®åžéçã®æž¬å®ãèšå®ãç°¡å確å®ã«
è¡ãªããããŸãåçš®ã¢ãŒãã®æž¬å®ãç°¡åã«è¡ãªã
ãããªã©è¡ç³ã®é£ç¶æž¬å®ã®åéã«ãããŠæ¥µããŠå€§
ããªå¹æããããããã®ã§ãããæŽã«ãæ¬çºæã¯
äžèšå®æœäŸã«éå®ããããã®ã§ãªããè¡ç³ä»¥å€ã®
è¡æ¶²æåã®æž¬å®ççš®ã
å¿çšã§ããããšã¯ãããŸã§
ããªãã As described above, the automatic continuous blood glucose measuring device that embodies the present invention repeatedly samples the sample solution, standard solution, and base solution in sequence while the sample solution is continuously flowing, and samples them in exactly the same flow path. Since the blood glucose level and its fluctuation pattern are measured while sequentially calibrating by flowing the fluid, it is possible to automatically, continuously, and accurately measure blood glucose levels and their fluctuation patterns without being affected by the changes in flow conditions that are characteristic of tube pumps. This makes it possible. Furthermore, each liquid is separated by an air layer and flows, so there is no cross-contamination, and since an immobilized enzyme membrane electrode is used, no defoaming device is required, simplifying the equipment, making it easy and reliable to measure and set the dilution rate of the sample liquid. It is extremely effective in the field of continuous blood glucose measurement, as it allows easy measurement in various modes. Furthermore, it goes without saying that the present invention is not limited to the above embodiments, and can be applied to various other applications such as measurement of blood components other than blood sugar.
第ïŒå³ã¯æ¬çºæã«ä¿ãè£
眮ã®ïŒäŸã瀺ãããã
ã¯ãã€ã€ã°ã©ã ã第ïŒå³ã¯ãµã³ããªã³ã°æ©æ§ã«ã
ããé液ç¶æ
ã®æš¡åŒå³ã第ïŒå³ã¯ãµã³ããªã³ã°æ©
æ§ã¯æŠç¥å³ã§ïœã¯åŽé¢å³ãïœã¯å¹³é¢å³ã第ïŒå³ã¯
OGTTã¢ãŒã枬å®ã®çµæã瀺ãã°ã©ããã€ãŒãã
第ïŒå³ã¯ç¬¬ïŒå³ã®å€åœ¢äŸã瀺ãã°ã©ããã€ãŒãã
第ïŒå³ã¯é»æ¥µåºåã®æéçå€åã瀺ãã°ã©ãã第
ïŒå³ã¯ä»ã®æž¬å®äŸã瀺ãSTARTã¢ãŒãã§ã®è¡ç³
å€æž¬å®çµæã瀺ãã°ã©ãã§ããã
ïŒâŠæ¡è¡éšãïŒâŠèŒæ£é液éšãïŒâŠãµã³ããªã³
ã°æ©æ§ãïŒâŠç·©è¡æ¶²é液éšãïŒâŠæž¬å®éšãïŒâŠæ
äœéšãïŒâŠæž¬å®ã»å¶åŸ¡åè·¯ãïŒïŒâŠã«ããŒãã«ã
ïŒïŒâŠè©Šæ液ã«ãããïŒïŒâŠè©Šæ液ãïŒïŒâŠã¹ã¿
ã³ããŒãïŒæ¶²ãïŒïŒâŠããŒã¹æ¶²ãïŒïŒâŠæšæºæ¶²ã«
ãããïŒïŒâŠããŒã¹æ¶²ã«ãããïŒïŒâŠãµã³ããªã³
ã°ããºã«ãïŒïŒâŠããºã«ããŠãŒããïŒïŒâŠç·©è¡
液ãïŒïŒâŠé»æ¥µãïŒïŒâŠæäœã¹ã€ãããïŒïŒâŠã
ãŒããŒããïŒïŒâŠãã€ã¯ãã³ã³ããŠãŒã¿ãŒãP1
ãP11âŠããŠãŒããã³ãã
Fig. 1 is a block diagram showing an example of the device according to the present invention, Fig. 2 is a schematic diagram of the liquid feeding state in the sampling mechanism, and Fig. 3 is a schematic diagram of the sampling mechanism, with a side view and b a plan view. , Figure 4 is
Graph chart showing the results of OGTT mode measurements,
Fig. 7 is a graph chart showing a modification of Fig. 4;
FIG. 5 is a graph showing temporal changes in electrode output, and FIG. 6 is a graph showing blood sugar level measurement results in START mode showing another measurement example. DESCRIPTION OF SYMBOLS 1...Blood collection part, 2...Calibration liquid feeding part, 3...Sampling mechanism, 4...Buffer liquid feeding part, 5...Measurement part, 6...Operation part, 7...Measurement/control circuit, 11...Catheter,
15...Sample solution cup, 16...Sample solution, 21...Standard 1 liquid, 22...Base solution, 23...Standard solution cup, 24...Base solution cup, 31...Sampling nozzle, 32...Nozzle tube, 41...Buffer solution, 52 ...electrode, 61...operation switch, 62...keyboard, 73...microcomputer, P 1
~P 11 ...tube pump.
Claims (1)
è¡ããè¡æ¶²äžã®ç¹å®æåãèªåçã«é£ç¶æž¬å®ãã
è£ çœ®ã«ãããŠãè©Šæ液ãšèŒæ£æ¶²ãšããŠã®æšæºæ¶²å
ã³ããŒã¹æ¶²ãšãããããäžæŠå°å ¥ããããªãŒããŒ
ãããŒã«ããã該ãªãŒããŒãããŒã«ããããå液
ãé 次繰ãè¿ãåžåŒããããºã«ãåäžã®æµè·¯ãçµ
ãŠå液ãåäžã®å²åã§ç·©è¡æ¶²ãšæ··åããããšå ±ã«
該混åããã液ã空æ°ã§åç¯ããããæ§æããã
ãããã«ãã該ãããã«ãããéããã液ãå°å ¥
ããããã®ã§è¡æ¶²äžã®ç¹å®æåã®æ¿åºŠãé£ç¶çèª
åçã«æž¬å®ããåºå®åé µçŽ èé»æ¥µãåã³æž¬å®çµæ
ã衚瀺ãã衚瀺åšãæããããšãç¹åŸŽãšããè¡æ¶²
æåã®èªåé£ç¶æž¬å®è£ 眮ã1. In a device that automatically and continuously measures specific components in blood that is continuously collected from a subject using a catheter, overflow is used to introduce a sample solution and a standard solution and base solution as calibration solutions, respectively. a cup, a nozzle that repeatedly suctions each liquid from the overflow cup in sequence, and a manifold configured to mix each liquid with a buffer solution in the same proportion through the same flow path and segment the mixed liquid with air. , into which the liquid sent from the manifold is introduced, and has an immobilized enzyme membrane electrode that continuously and automatically measures the concentration of a specific component in the blood, and a display that displays the measurement results. Automatic continuous measurement device for components.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56063160A JPS57178151A (en) | 1981-04-24 | 1981-04-24 | Automatic and continuous measuring apparatus of blood component |
EP82302100A EP0064369B1 (en) | 1981-04-24 | 1982-04-23 | A device for automatically and continuously measuring the constituent parts of blood |
US06/371,482 US4512348A (en) | 1981-04-24 | 1982-04-23 | Device for automatically and continuously measuring the constituent parts of blood |
DE8282302100T DE3273657D1 (en) | 1981-04-24 | 1982-04-23 | A device for automatically and continuously measuring the constituent parts of blood |
BE0/207920A BE892964A (en) | 1981-04-24 | 1982-04-26 | DEVICE FOR AUTOMATICALLY AND CONTINUOUSLY MEASURING BLOOD ELEMENTS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56063160A JPS57178151A (en) | 1981-04-24 | 1981-04-24 | Automatic and continuous measuring apparatus of blood component |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57178151A JPS57178151A (en) | 1982-11-02 |
JPH0247700B2 true JPH0247700B2 (en) | 1990-10-22 |
Family
ID=13221202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56063160A Granted JPS57178151A (en) | 1981-04-24 | 1981-04-24 | Automatic and continuous measuring apparatus of blood component |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57178151A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62186846A (en) * | 1986-02-13 | 1987-08-15 | æ¥æ©è£ æ ªåŒäŒç€Ÿ | Method for measuring concentration of specific substance in continuous sampling blood specimen |
AT389589B (en) * | 1987-04-03 | 1989-12-27 | Avl Verbrennungskraft Messtech | DEVICE FOR SELECTIVE FEEDING OF AN ANALYZER |
JPH0389168A (en) * | 1989-08-31 | 1991-04-15 | Kanzaki Paper Mfg Co Ltd | Flow type measuring apparatus and measuring method using the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53109691A (en) * | 1977-03-07 | 1978-09-25 | Hitachi Ltd | Flow cell type analysis method and apparatus liquid for specimen |
JPS54106962A (en) * | 1978-02-09 | 1979-08-22 | Akira Yoda | Chaff crusher |
-
1981
- 1981-04-24 JP JP56063160A patent/JPS57178151A/en active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53109691A (en) * | 1977-03-07 | 1978-09-25 | Hitachi Ltd | Flow cell type analysis method and apparatus liquid for specimen |
JPS54106962A (en) * | 1978-02-09 | 1979-08-22 | Akira Yoda | Chaff crusher |
Also Published As
Publication number | Publication date |
---|---|
JPS57178151A (en) | 1982-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0064369B1 (en) | A device for automatically and continuously measuring the constituent parts of blood | |
US6434409B1 (en) | Determination of glucose concentration in tissue | |
JP3220154B2 (en) | Calibration solution for analysis of biological fluid and method of using the same | |
US4535786A (en) | Measurement of body fluid chemistry | |
AU697232B2 (en) | In situ calibration system for sensors located in a physiologic line | |
EP0242644B1 (en) | Blood component monitoring system | |
JPH0365972B2 (en) | ||
US4818361A (en) | Combined pH and dissolved carbon dioxide gas sensor | |
US6117099A (en) | System and method for noninvasive hemodynamic measurements in hemodialysis shunts | |
JPH04341241A (en) | Method for measuring bodily fluid component and instrument | |
Beyer et al. | Recording of subcutaneous glucose dynamics by a viscometric affinity sensor | |
US20080153118A1 (en) | Method and Device for Determining the Glucose Concentration in Tissue Liquid | |
JPH05253293A (en) | Monitoring of hemodialysis progress and device therefor | |
JPH03273153A (en) | Measuring instrument and measuring method for liquid component | |
JPH0778480B2 (en) | Method for automatic calibration of solute concentration measuring electrode in solution | |
Sibbald et al. | Online patient-monitoring system for the simultaneous analysis of blood K+, Ca 2+, Na+ and pH using a quadruple-function ChemFET integrated-circuit sensor | |
Rhemrev-Boom et al. | A lightweight measuring device for the continuous in vivo monitoring of glucose by means of ultraslow microdialysis in combination with a miniaturised flow-through biosensor | |
JPH0247700B2 (en) | ||
WO2011104710A1 (en) | Device, system and method for in-flow analyte concentration detection | |
JPH0334723B2 (en) | ||
RU2672354C2 (en) | Method for continuous monitoring of analyte content in blood | |
Walton et al. | Comparison of blood gas and electrolyte test results from the Gem-Stat and CDI-300 versus a conventional laboratory analyzer | |
Heidrich et al. | Continuous Analysis in Extracorporeally Circulating Blood-A Rat Model Applying Flow-Through Ion-Selective Electrodes for the Measurement of Ca2+, K+, Na+ and pH | |
CN1058471A (en) | Patient's liquid (gas) liquid (gas)-phase gas monitoring instrument | |
JPS58152537A (en) | Continuous monitor apparatus of substance in blood |